ADGRG6 and urinary bladder cancer: In this study, the amplification refractory mutation system combined with quantitative real‐time PCR (ARMS‐qPCR) method was developed to rapidly and sensitively detect the specific mutations of ADGRG6 enhancer providing a flexible and easy way to screen bladder cancer.